These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Prevalence of antibodies to hepatitis C virus in sera from patients with systemic necrotizing vasculitis. Theilmann L, Gmelin K, Kallinowski B, Kommerell B, Koderisch J, Andrassy K. Nephron; 1991; 57(4):482. PubMed ID: 1646410 [No Abstract] [Full Text] [Related]
26. Anti-HCV reactivity in dialysis patients: discrepancies between first and second generation tests. Beccari M, Sorgato G, Rizzolo L, Veneroni G. Nephron; 1993; 63(2):238. PubMed ID: 7680775 [No Abstract] [Full Text] [Related]
28. Hepatitis C core antibody detection in acute hepatitis and cirrhosis patients from Tunisia. Coursaget P, Simpson B, el Goulli N, Ben Khelifa H, Kastally R. Pathol Biol (Paris); 1992 Jun; 40(6):646-8. PubMed ID: 1383914 [Abstract] [Full Text] [Related]
29. [Seroprevalence of hepatitis C virus antibodies in obstetric patients at the Nuevo Hospital Civil de Guadalajara]. Gamboa R, Gaxiola Castro R, Guana Flores R, Silva Maciel CA, Becerra Leyva G. Ginecol Obstet Mex; 1994 Dec; 62():399-402. PubMed ID: 7530675 [Abstract] [Full Text] [Related]
31. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery. García-Bengoechea M, Emparanza JI, Sarriugarte A, Cortés A, Vega JL, González F, Arenas JI. Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):237-41. PubMed ID: 7538032 [Abstract] [Full Text] [Related]
32. Significance of NS3 and NS5 antigens in screening for HCV antibody. Courouce AM, Bouchardeau F, Girault A, Le Marrec N. Lancet; 1994 Apr 02; 343(8901):853-4. PubMed ID: 7511195 [No Abstract] [Full Text] [Related]
34. Development of screening and confirmation tests for antibodies to hepatitis C virus. Couroucé AM, Janot C. Curr Stud Hematol Blood Transfus; 1994 Apr 02; (61):36-48. PubMed ID: 7525156 [No Abstract] [Full Text] [Related]
35. Hepatitis C virus antibodies in dialysis pediatric patients. Di Loreto M, Ferrante M, Panaro A, Sorino P, Collela V, Caringella DA. Nephron; 1992 Apr 02; 61(3):365-6. PubMed ID: 1323793 [Abstract] [Full Text] [Related]
36. Hepatitis C in asymptomatic British blood donors with indeterminate seropositivity. Mutimer DJ, Harrison RF, O'Donnell KB, Shaw J, Martin BA, Atrah H, Ala FA, Skidmore S, Hubscher SG, Neuberger JM. BMJ; 1994 Oct 01; 309(6958):847-8. PubMed ID: 7524875 [No Abstract] [Full Text] [Related]
37. Hepatitis C virus antibodies in patients on hemodialysis. San Miguel G, Crespo J, Echevarria S, D'Francisco A, Gomez Ullate P, Pons Romero F. Infect Control Hosp Epidemiol; 1992 May 01; 13(5):254, 256. PubMed ID: 1375612 [No Abstract] [Full Text] [Related]
38. [Application of C8-2Ag-Ab system for the diagnosis of hepatitis C]. Mizuno K, Kawahara T, Fujiyama S, Yano M. Nihon Rinsho; 1991 Feb 01; 49(2):330-4. PubMed ID: 1707102 [No Abstract] [Full Text] [Related]
39. Prevalence of anti-hepatitis C virus antibodies among patients with alcoholic liver disease, supplemented by 4-RIBA. Laurent-Puig P, Dussaix E, Lecoz Y, Martes P, Buffet C. Dig Dis Sci; 1992 Jan 01; 37(1):156-7. PubMed ID: 1309449 [No Abstract] [Full Text] [Related]
40. Normal aminotransferase concentrations in patients with antibodies to hepatitis C virus. Bruno S, Rossi S, Petroni ML, Villa E, Zuin M, Podda M. BMJ; 1994 Mar 12; 308(6930):697. PubMed ID: 8142795 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]